INPLASY202660013

SGLT-2 Inhibitors Across the Complete Spectrum of Chronic Kidney Disease Aetiology: A Meta-Analysis of 21 Trials and 78,614 Participants Through May 2026

Keywords: SGLT-2 inhibitor; chronic kidney disease; IgA nephropathy; eGFR; albuminuria; meta-analysis; empagliflozin; dapagliflozin; canagliflozin; renoprotection.

Read and download full-text here - PDF 202660013

Review Status: ongoing